Live from the NIH registry
Studies recruiting near Wichita right now
Top 25 of 154 recruiting studies, sorted by proximity — each links to its official registry page
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
Cardiovascular Research Institute of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Edwards Lifesciences
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cancer Center of Kansas-Wichita Medical Arts Tower — Wichita, Kansas (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Cancer Center of Kansas ( Site 0004) — Wichita, Kansas (0.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Wesley Medical Center — Wichita, Kansas (0.4 mi)
· Sponsor: National Cancer Institute (NCI)
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Kansas Nephrology Research Institute LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Amgen
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Bowel; Stricture
Phase 3
Interventional 171 participants sought
Kansas Gastroenterology, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: GIE Medical
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8
Phase 3
Interventional 486 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: NRG Oncology
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Heartland Research Associates, LLC - An AMR Company — Wichita, Kansas (0.4 mi)
· Sponsor: Kallyope Inc.
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: NRG Oncology
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Osteoarthritis
Phase 3
Interventional 800 participants sought
AMR Clinical — Newton, Kansas (24.7 mi)
· Sponsor: Eli Lilly and Company
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms, Castration-Resistant
Phase 3
Interventional 800 participants sought
Cancer Center of Kansas Heritage Plaza Medical Building — Wichita, Kansas (0.4 mi)
· Sponsor: Janssen Research & Development, LLC
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Obesity With Diabetes, Overweight With Diabetes
Phase 3
Interventional 1,156 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Phase 3
Interventional 466 participants sought
Cancer Center of Kansas-Wichita Medical Arts Tower — Wichita, Kansas (0.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 500 participants sought
Cardiovascular Research Institute of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Orchestra BioMed, Inc
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Phase 3
Interventional 250 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Ferring Pharmaceuticals
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 750 participants sought
GSK Investigational Site — El Dorado, Kansas (27.8 mi)
· Sponsor: GlaxoSmithKline
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Obesity
Phase 3
Interventional 1,200 participants sought
Kailera Clinical Site — Newton, Kansas (24.7 mi)
· Sponsor: Kailera
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Ascension Via Christi Hospitals Wichita — Wichita, Kansas (0.4 mi)
· Sponsor: NRG Oncology
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
West Houston Area Clinical Trial Consultants — Wichita, Kansas (0.4 mi)
· Sponsor: Novo Nordisk A/S
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2
Interventional 325 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: CG Oncology, Inc.
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
Kidney Calculi; Ureteral Calculi
N/A
Interventional 101 participants sought
Wichita Urology Group — Wichita, Kansas (0.4 mi)
· Sponsor: Avvio Medical
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Aortic Stenosis, Calcific, Aortic Valve Stenosis
N/A
Interventional 2,250 participants sought
Ascension Via Christi St. Francis — Wichita, Kansas (0.4 mi)
· Sponsor: Edwards Lifesciences
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
Esophageal Stricture
Phase 3
Interventional 198 participants sought
Kansas Gastroenterology, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: GIE Medical
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Phase 3
Interventional 11,000 participants sought
Kansas Nephrology Research Institute, LLC — Wichita, Kansas (0.4 mi)
· Sponsor: Boehringer Ingelheim
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Cancer Weight Loss
Phase 2
Interventional 120 participants sought
Cancer Centers of Kansas — Wichita, Kansas (0.4 mi)
· Sponsor: Endevica Bio